ASX:ACL
Australian Clinical Labs Limited · ASX · Healthcare · AUD · FY for 2026
Figures on this page computed 2026-11-08 02:32 UTC
Last close
n/aAUD
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
27.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
- Computed from the filing for 2026
8.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
3.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
21.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
2.26Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
4.0%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
Safety is the furthest below its sector's middle: 0.29 against 0.57 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales1.19x
Its own average over 10 years, 613.3M.
- Profit0.67x
Its own average over 10 years, 35.2M.
- Free cash flow1.40x
Its own average over 10 years, 109.7M.
- Debt1.54x
Its own average over 10 years, 218.9M.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 1.54 times.
The filed years, as a table
10Each line is 100 at 2017-06-30, the first year we hold.
| Filed year | Sales | Shares in issue |
|---|---|---|
| 2017-06-30 | 100.0 | 100.0 |
| 2018-06-30 | 110.7 | 100.0 |
| 2019-06-30 | 131.2 | 100.0 |
| 2020-06-30 | 143.5 | 100.0 |
| 2021-06-30 | 188.7 | 75.2 |
| 2022-06-30 | 291.2 | 99.6 |
| 2023-06-30 | 203.7 | 99.4 |
| 2024-06-30 | 203.0 | 98.6 |
| 2025-06-30 | 218.2 | 94.0 |
| 2026-06-30 | 214.7 | 95.1 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- AUD
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- AUD
Figures behind the shape
Growth
2.6%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate2.6%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
Five-year EPS growth rate-21.4%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
One-year change in net income-26.9%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
Returns on capital
8.6%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital8.6%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equity15.9%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets4.0%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
20.6%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin20.6%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating margin8.4%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
Net margin3.3%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow margin21.1%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
27.0xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings27.0x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
- Computed from the filing for 2026
Price to book4.2x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDA4.8x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ratio0.8x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
2.26safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity2.26
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio0.54
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coverage3.3x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Score2.61
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
4.0%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield4.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
Payout ratio103.7%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ratio6.3x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- AUD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.